慢性肾脏病3～5期患者的血清超敏cTnI水平及其与肾脏相关指标的关系

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (401 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the level of serum hypersensitive cardiac troponin I (cTnI) in patients of chronic kidney disease (CKD) from 3 to 5 stage without renal replacement therapy. Methods A total of 180 patients of CKD from 3 to 5 stage without renal replacement therapy, severe arrhythmia, acute myocardial infarction and sepsis were selected in the First Affiliated Hospital of Hainan Medical University from January 2016 to November 2017. Then their serum hypersensitivity cTnI were collected, and the correlation between the level of serum hypersensitivity cTnI and glomerular filtration rate (GFR), age, serum creatinine (Scr), blood urea nitrogen (BUN), blood Cystatin-C (CYS-C) and blood albumin (ALB) were analyzed. Results The rank sum test of multiple independent samples showed that the level of serum hypersensitivity cTnI in patients of CKD from 3 to 5 stage without renal replacement therapy was different, and the difference was statistically significant (P ＜ 0.05). Pearson bivariate correlation displayed hypersensitivity cTnI was linearly correlated with CKD staging, GFR and CYS-C (P ＜ 0.05), and was not linearly correlated with Scr, BUN, ALB and age (P ＞ 0.05). The stepwise multiple linear regression analysis showed that the hypersensitive cTnI regression equation was Y = -0.043+0.023X (Y：cTnI，X：CKD3～5). Conclusion The reference value of cTnI in the patients of CKD from 3 to 5 stage can be corrected according to the hypersensitive cTnI regression equation, and then it can be used as a reference for clinical decision of CKD.

Key words： Chronic kidney disease Hypersensitive cardiac troponin I Acute coronary syndrome Acute myocardial infarction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Shanzhi1 ZHU Yongjun1 YE Feng2▲ LI Guoquan1 WEI Chuanwa1 HAN Feng2 LIANG Haiqin1 ZHONG Liangbao1

Cite this article:

WANG Shanzhi1 ZHU Yongjun1 YE Feng2▲ LI Guoquan1 WEI Chuanwa1 HAN Feng2 LIANG Haiqin1 ZHONG Liangbao1. Serum hypersensitivity cTnI level and its correlation with kidney related indicators in patients of chronic kidney disease from 3 to 5 stage[J]. 中国医药导报, 2018, 15(15): 69-71.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I15/69

[1] Collins AJ，Foley RN，Chavers B，et al. United States Renal Data System 2011 Annual Data Report：Atlas of chronic kidney disease & end-stage renal disease in the United States [J]. Am J Kidney Dis，2012，59（1 Suppl）：A7，e1-e420.
[2] Goodkin DA，Young EW，Kurokawa K，et al. Mortality among hemodialysis patients in Europe，Japan，and the United States：case-mix effects [J]. Am J Kidney Dis，2004，44（5 Suppl 2）：16-21.
[3] Roongsritong C，Warraich I，Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction：incidence and clinical significance [J]. Chest，2004， 125（5）：1877-1884.
[4] K/DOQI clinical practice guidelines for chronic kidney disease：evaluation，classification，and stratification [J]. Am J Kidney Dis，2002，39（2 Suppl 1）：S1-S266.
[5] Haaf P，Drexler B，Reichlin T，et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease [J]. Circulation，2012，126（1）：31-40.
[6] Bodor GS，Porterfield D，Voss EM，et al. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue [J]. Clin Chem，1995，41（12 Pt 1）：1710-1715.
[7] Lippi G，Targher G，Franchini M，et al. Genetic and biochemical heterogeneity of cardiac troponins：clinical and laboratory implications [J]. Clin Chem Lab Med，2009，47（10）：1183-1194.
[8] Fuchs S，Kornowski R，Mehran R，et al. Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes：the potential role of early percutaneous revascularization [J]. J Am Coll Cardiol，1999，34（6）：1704-1710.
[9] Dalal JJ，Ponde CK，Pinto B，et al. Time to shift from contemporary to high-sensitivity cardiac troponin in diagnosis of acute coronary syndromes [J]. Indian Heart J，2016，68（6）：851-855.
[10] 梁惠清，刘俊.肌钙蛋白T和肌钙蛋白I升高在非冠状动脉疾病中的特点[J].心血管病学进展，2014，35（4）：506-510.
[11] Rosjo H，Varpula M，Hagve TA，et al. Circulating high sensitivity troponin T in severe sepsis and septic shock：distribution，associated factors，and relation to outcome [J]. Intensive Care Med，2011，37（1）：77-85.
[12] Bass A，Patterson JH，Adams KF，et al. Perspective on the clinical application of troponin in heart failure and states of cardiac injury [J]. Heart Fail Rev，2010，15（4）：305-317.
[13] Morrow DA，Cannon CP，Jesse RL，et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines：clinical characteristics and utilization of biochemical markers in acute coronary syndromes [J]. Clin Chem，2007，53（4）：552-574.
[14] Schulz O，Kromer A. Cardiac troponin I：a potential marker of exercise intolerance in patients with moderate heart failure [J]. Am Heart J，2002，144（2）：351-358.
[15] 翟金俊.血清肌钙蛋白Ⅰ、肌酸激酶同工酶—Ⅱ测定在肾衰患者中的作用[J]．心血管病防治知识：学术版，2011， 2（1）：22-24.
[16] 陈瑞珍，卜丽萍，虞勇，等.慢性心力衰竭患者血清中cTnI/T与不同心血管疾病的关系[J]．复旦学报：医学版，2005，32（6）：27-30.
[17] 霍洁，东明，张初吉，等.慢性肾功能衰竭患者血清心肌肌钙蛋白I的研究[J].中国急救复苏与灾害医学杂志，2011，9（6）：756-758.
[18] Francis GS，Tang WH. Cardiac troponins in renal insufficiency and other non-ischemic cardiac conditions [J]. Prog Cardiovasc Dis，2004，47（3）：196-206.
[19] Zumrutdal A，Bakinen O，Ucan H，et al. Relationship between uremic myopathy and false-positive cardiac troponin T test [J]. Nephron，2000，86（4）：522-523.
[20] Diris JH，Hackeng CM，Kooman JP，et al. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients [J]. Circulation，2004，109（1）：23-25.